Jump to content

Mally

Members
  • Posts

    295
  • Joined

  • Last visited

  • Days Won

    6

Topics posted by Mally

  1.  
    • 7 replies
    • 2,358 views
  2.  
    • 9 replies
    • 450 views
  3.  

    Biopsy results

    By Mally, in GENERAL

    • 10 replies
    • 1,347 views
  4.  

    Ct scan results

    By Mally, in NSCLC GROUP

    • 13 replies
    • 1,078 views
  5.  

    First chemo session

    By Mally, in CHEMOTHERAPY

    • 2 replies
    • 1,113 views
  6.  

    Follow up scans

    By Mally, in NSCLC GROUP

    • 4 replies
    • 728 views
  7.  

    Future scans

    By Mally, in NSCLC GROUP

    • 8 replies
    • 669 views
  8.  

    G.i. issues

    By Mally, in NSCLC GROUP

    • 3 replies
    • 722 views
  9.  

    Gemsitabine

    By Mally, in CHEMOTHERAPY

    • 0 replies
    • 614 views
  10.  
    • 1 reply
    • 662 views
  11.  
    • 9 replies
    • 528 views
  12.  
    • 8 replies
    • 875 views
  13.  

    Lung cancer 1 2

    By Mally, in INTRODUCE YOURSELF!

    • 38 replies
    • 2,411 views
  14.  

    Mally

    By Mally, in GENERAL

    • 17 replies
    • 1,598 views
  15.  

    Mally

    By Mally, in GENERAL

    • 10 replies
    • 1,758 views
  16.  

    Mally

    By Mally, in GENERAL

    • 20 replies
    • 3,337 views
  17.  

    Mally

    By Mally, in GENERAL

    • 19 replies
    • 2,185 views
  18.  

    Mally

    By Mally, in GENERAL

    • 12 replies
    • 674 views
  19.  

    Mally

    By Mally, in LUNG CANCER MUTATIONS

    • 3 replies
    • 6,394 views
  20.  
    • 0 replies
    • 1,957 views
  21.  
    • 8 replies
    • 2,427 views
  22.  

    Mally

    By Mally, in IMMUNOTHERAPY

    • 3 replies
    • 1,257 views
  23.  

    Mally

    By Mally, in IMMUNOTHERAPY

    • 7 replies
    • 1,823 views
  24.  

    Mally

    By Mally, in IMMUNOTHERAPY

    • 21 replies
    • 2,188 views
  25.  

    Mally

    By Mally, in NSCLC GROUP

    • 8 replies
    • 706 views
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.